<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0"><channel><title>Individual feed for https://www.medscape.com/cx/rssfeeds/2700.xml</title><link>https://www.medscape.com/cx/rssfeeds/2700.xml</link><description>Individual feed output.</description><lastBuildDate>Thu, 25 Sep 2025 15:09:32 GMT</lastBuildDate><generator>PyRSS2Gen-1.1.0</generator><docs>http://blogs.law.harvard.edu/tech/rss</docs><item><title>Stop Young Physician Suicide</title><link>https://www.medscape.com/viewarticle/michigan-psychiatry-professors-mission-stop-young-physician-2025a1000pq9?src=rss</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture2.png</image_url><description>A friendâ€™s death and his own struggles in residency set Srijan Sen on path toward prevention. Medscape Medical News</description><pubDate>Thu, 25 Sep 2025 17:43:37 GMT</pubDate></item><item><title>Is Lower-Dose Ribociclib Equally Effective in Breast Cancer?</title><link>https://www.medscape.com/viewarticle/lower-dose-ribociclib-equally-effective-breast-cancer-2025a1000pnx?src=rss</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture7.png</image_url><description>Researchers compared ribociclib 400 mg with ribociclib 600 mg plus a nonsteroidal aromatase inhibitor in patients with hormone receptor-positive/ERBB2...</description><pubDate>Thu, 25 Sep 2025 16:05:00 GMT</pubDate></item><item><title>Ribociclib Shows Lasting Benefit in Early Breast Cancer</title><link>https://www.medscape.com/viewarticle/ribociclib-shows-lasting-benefit-early-breast-cancer-2025a1000pol?src=rss</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture5.png</image_url><description>Researchers examined invasive disease-free survival rates at 4 years in a randomized phase 3 trial of adjuvant treatment for women and men with HR+/ER...</description><pubDate>Thu, 25 Sep 2025 16:05:00 GMT</pubDate></item><item><title>Oral IL-23 Inhibitor Bests JAK Inhibitor in Psoriasis Trials</title><link>https://www.medscape.com/viewarticle/novel-oral-il-23-inhibitor-superior-jak-inhibitor-psoriasis-2025a1000ppj?src=rss</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture1.png</image_url><description>A nonbiologic oral IL-23 inhibitor is more effective and safer than an approved oral JAK inhibitor for moderate-to-severe psoriasis in a head-to-head ...</description><pubDate>Thu, 25 Sep 2025 14:35:10 GMT</pubDate></item><item><title>Is Single-Test TB Screening Enough Before Biologics?</title><link>https://www.medscape.com/viewarticle/single-test-tuberculosis-screening-enough-before-biologic-2025a1000pp1?src=rss</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture1.png</image_url><description>Using QuantiFERON-TB Gold as the sole screening test before starting biologic therapy reduces TB diagnoses compared with using dual testing and does n...</description><pubDate>Thu, 25 Sep 2025 14:17:34 GMT</pubDate></item></channel></rss>